Neoadjuvant Cardonilizumab Combined With Neoadjuvant Chemoradiotherapy Can Resect Locally Advanced Esophageal Squamous Cell Carcinoma

NCT07699185 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

336

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

BIOLOGICAL: Cardonilizumab
DRUG: Paclitaxel
DRUG: Cisplatin
RADIATION: neoadjuvant chemoradiotherapy

Sponsor

Tongji Hospital